0 Tuberculosis: ‘Suicide’ toxin–antitoxin system identified as a drug target
Researchers have investigated a toxin–antitoxin system in tuberculosis as a therapeutic target, providing the first high-resolution details.
Browsing: Bacterial > Tuberculosis
0 Shorter treatment duration a possibility for pulmonary TB
New data analysis of three clinical trials has suggested that a precision medicine approach could allow some pulmonary TB patients to have significantly shorter treatment periods.
0 Highlights of the WHO Global Tuberculosis Report
On the day of UNGA’s first-ever high-level meeting on tuberculosis we summarize the key points from the WHO 2018 Global Tuberculosis Report and what this meeting could mean for accelerating progress.
0 Tuberculosis care: variation and deficits uncovered in urban India
A study using standardized patients has reported that private practitioners in India are delivering a wide range of often inadequate care to tuberculosis patients.
0 Novel non-antibiotic for tuberculosis successfully tested
Scientists at the University of Manchester (UK) have developed the first non-antibiotic drug to successfully treat tuberculosis (TB) in animal…
0 From TB to leprosy: financial model reveals where pipelines and investments might fall short
Financial modelling has been used to estimate the costs and likelihood of candidate medicines, vaccines, diagnostics and technologies launching, revealing gaps in the pipeline and in funding.
0 New trials a game-changer for latent TB treatment
Clinical trial data has proved a novel, short therapy more effective and safe for the treatment of latent tuberculosis than the standard therapy in both adults and children.
0 Neurotuberculosis, from treatment to politics – an interview with Guy Thwaites
Guy Thwaites, Director of the Oxford University Clinical Research Unit/Wellcome Program in Vietnam, speaks on neurotuberculosis and the challenges it faces in terms of treatment, HIV co-infection and the political will necessary for change.
0 A peek behind the paper – better than a pound of cure; steps to prevent multidrug resistant tuberculosis in adults and children
Take a look behind the science of a recent Future Microbiology article, entitled ‘Better than a pound of cure: preventing the development of multidrug-resistant tuberculosis’ as we ask the authors about the challenges currently facing multidrug resistant (MDR) tuberculosis and what the future might hold.
0 In focus: Tuberculosis
World Tuberculosis Day 2018 (March 24th) is an annual event aiming to raise public awareness around the health, economic and…
